Blackstone Life Sciences
Corporate VCNew York · Series A–Late Stage · 9 people tracked
Also known as BLACKSTONE ALTERNATIVE ASSET MANAGEMENT L.P. · BLACKSTONE ALTERNATIVE CREDIT ADVISORS LP · BLACKSTONE ALTERNATIVE INVESTMENT ADVISORS LLC · BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C. · BLACKSTONE ASSET BASED FINANCE ADVISORS LP · BLACKSTONE CLO MANAGEMENT LLC (MANAGEMENT SERIES) · BLACKSTONE CREDIT BDC ADVISORS LLC · BLACKSTONE CREDIT SYSTEMATIC STRATEGIES LLC · BLACKSTONE EUROPE FUND MANAGEMENT S.A.R.L. · BLACKSTONE GROWTH ADVISORS L.L.C. · BLACKSTONE INFRASTRUCTURE ADVISORS L.L.C. · BLACKSTONE IRELAND FUND MANAGEMENT LIMITED · BLACKSTONE IRELAND LIMITED · BLACKSTONE ISG-I ADVISORS L.L.C. · BLACKSTONE ISG-II ADVISORS L.L.C. · BLACKSTONE LIQUID CREDIT ADVISORS I LLC · BLACKSTONE LIQUID CREDIT STRATEGIES LLC · BLACKSTONE MANAGEMENT PARTNERS L.L.C. · BLACKSTONE MULTI-ASSET ADVISORS L.L.C. · BLACKSTONE PRIVATE CREDIT STRATEGIES LLC · BLACKSTONE PRIVATE INVESTMENTS ADVISORS L.L.C. · BLACKSTONE PROPERTY ADVISORS L.P. · BLACKSTONE REAL ESTATE ADVISORS EUROPE L.P. · BLACKSTONE REAL ESTATE ADVISORS L.P. · BLACKSTONE REAL ESTATE ADVISORS V L.P. · BLACKSTONE REAL ESTATE SPECIAL SITUATIONS ADVISORS L.L.C. · BLACKSTONE STRATEGIC ALLIANCE ADVISORS L.L.C. · BLACKSTONE STRATEGIC CAPITAL ADVISORS, L.L.C. · BLACKSTONE TACTICAL OPPORTUNITIES ADVISORS L.L.C. · BX REIT ADVISORS L.L.C. · BXMT ADVISORS L.L.C. · CLARUS VENTURES, LLC · CLOVER CREDIT MANAGEMENT, LLC · CT INVESTMENT MANAGEMENT CO., LLC · HARVEST FUND ADVISORS LLC · STRATEGIC PARTNERS FUND SOLUTIONS ADVISORS L.P.
Investment thesis
BXLS collaborates with leading pharmaceutical, biotech and medical technology companies to fund and advance late-stage clinical development of critical-path products addressing unmet medical needs. It combines clinical, commercial and operational expertise with Blackstone's global network, capital access and infrastructure to select and advance promising products and companies. The strategy aims to fill a funding gap between the demand for development capital and what pharma and MedTech R&D budgets can supply. BXLS seeks attractive, largely market- and interest-rate-uncorrelated returns at lower risk by capturing value directly from the products it funds rather than through equity exposure, sometimes forming and growing companies around promising clinical assets.
Source: firm website, verified Aug 11, 2026.
Team · 9 people
from public directories
What they invest in
from 2 of 3 portfolio companiesBiotech ×2Medical Devices ×2Deep Tech ×1Digital Health ×1
HQs:United States×1
Investments · 3 tracked
founders shown can be your intro pathAlnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical Devices
Founded by BXLS with Novartis in February 2019 to advance next-generation targeted therapies for high-risk cardiovascular patients; sold to Novartis in April 2025.
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Lorence Kim(Executive Officer)Robert Langer(Director)Peter Hutt(Director)John Mendlein(Director)James R. Kasinger(Executive Officer)Elizabeth Nabel(Director)
Portfolio news
latest coverage across their companiesModerna · forbes.com · Jul 19, 2026
Alnylam · investing.com · Jul 17, 2026
Frequently asked questions
- What stage does Blackstone Life Sciences invest at?
- Blackstone Life Sciences invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is Blackstone Life Sciences's typical check size?
- Blackstone Life Sciences typically writes checks of $20M – $60M.
- What sectors does Blackstone Life Sciences focus on?
- Blackstone Life Sciences focuses on Biotech, Crypto & Web3, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
- Where is Blackstone Life Sciences located?
- Blackstone Life Sciences is headquartered in New York, US.
Images
Similar investors
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It invests internationally in transformative technology companies.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Alumni Ventures (AV) is a venture firm that gives accredited individual investors access to professionally managed, diversified venture portfolios by co-investing alongside leading lead VC firms. It offers annual funds, syndicate deal-by-deal investing, and various investor clubs.